Large gap with delayed quotes
Analysis date: 26.08.2025
Global Evaluation
Neutral
Neutral
The stock is classified in the neutral zone since 13.06.2025.
Interest
Very weak
Very weak
One star since 15.07.2025.
Earnings Rev Trend
Negative
Negative
Compared to seven weeks ago, the analysts have lowered their earnings per share estimates. This negative trend began 15.07.2025 at a price of 1513.20.
Evaluation
Neutral
Neutral
Based on its growth potential and our own criteria, we believe the share price is currently fairly priced.
MT Tech Trend
Negative
Negative
The dividend-adjusted forty day technical trend is negative since 20.06.2025.
4wk Rel Perf
-8.97%
-8.97%
The four-week dividend-adjusted underperformance versus STOXX600 is 8.97%.
Sensibility
Middle
Middle
The stock has been on the moderate-sensitivity level since 13.06.2025.
Bear Market Factor
Middle
Middle
On average, the stock is likely to decline with the index.
Bad News Factor
Low
Low
When the stock's pressure is specific, the market sanction on average is 2.53%.
Mkt Cap in $bn
54.06
54.06
With a market capitalization >$8bn, ADYEN is considered a large-cap stock.
G/PE Ratio
0.89
0.89
A ratio (Forecasted Growth + Estimated Dividend Yield/ Estimated Price Earnings) below 0.9 indicates that investors must pay a premium for the estimated growth potential: premium.
LT P/E
29.65
29.65
The estimated PE is for the year 2027.
LT Growth
26.36%
26.36%
The annualized growth estimate is for the current year to 2027.
Avg. Nb analysts
27
27
Over the last seven weeks, an average of 27 analysts provided earnings per share estimates.
Dividend Yield
0.00%
0.00%
The company is not paying a dividend.
Beta
150
150
For 1% of index variation, the stock varies on average by 1.50%.
Correlation
0.55
0.55
55.08% of stock movements are explained by index variations.
Value at Risk
343.54
343.54
The value at risk is estimated at EUR 343.54. The risk is therefore 24.00%. This value is based on the historical volatility for a medium time period (1 month) with a confidence of 95%.
First Analysis Date
05.10.2018
05.10.2018